| 1. |
- Berne, C, et al.
(författare)
-
Diabetes mellitus--nya svenska nationella riktlinjer
- 1997
-
Ingår i: Nordisk medicin. - 0029-1420. ; 112:5, s. 151-153
-
Tidskriftsartikel (refereegranskat)abstract
- In 1996, national guidelines for the care and treatment of patients with diabetes mellitus were drawn up by specialists, in collaboration with representatives of the patient organisation, diabetes nurses, the professional associations of various medical specialties and central authorities. The national programme is divides into three parts: summarised information for decision-makers, clinical guidelines and complete information for patients. The guidelines are designed to provide a basis for treatment programmes at the local level. Among other things, the national guidelines stress the importance of the diabetes nurse both in primary and tertiary care, and emphasise the need of regional centers providing access to information and education and promoting the development of treatment. Another important aspect is fostering the influence of patient organisations at the local level, in order for the guidelines to have an impact on the quality of care for the individual patient.
|
|
| 2. |
|
|
| 3. |
- Gudbjörnsdottir, Soffia, 1962, et al.
(författare)
-
[The National Diabetes Registry 1996-2003. Quality assessment shows improved diabetic care]
- 2004
-
Ingår i: Lakartidningen. - 0023-7205. ; 101:47
-
Forskningsöversikt (refereegranskat)abstract
- The Swedish National Diabetes Register presents results during the period 1996-2003. Quality of care data from more than 75,000 diabetic patients (2003) treated at medical departments and primary health care centres are evaluated concerning national goals of HbA1c < 6.5% and BP < 140/85 mm Hg, the prevalence of lipid treatment, smoking etc. The national goals of HbA1c and BP were reached with increasing degree in cross-sectional analysis during the period, and were achieved by 33% and 71% at medical departments, and by 61% and 48% in primary health care in 2003. A similar tendency was also seen in longitudinal analysis of subgroups 1996-2003. The use of antihypertensive and lipid-lowering drugs was also considerably increased. This should imply a reduction of the risk for diabetic complications. As the national goals are still difficult to reach, individual goals should be set for the treatment.
|
|
